LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

Cochlear™ is proud to announce FDA approval for the Cochlear Nucleus® Hybrid Implant System. The system is a groundbreaking advancement that will change the way hearing loss is treated in the United ...

Individuals with UHL/SSD can now seek treatment with a cochlear implant from Cochlear to hear with both ears. Cochlear Limited obtained U.S. Food and Drug Administration (FDA) approval of Cochlear™ ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cochlear ( (AU:COH)) just unveiled an ...

Engaging the brain’s plasticity by stimulating the locus coeruleus, a region in the brainstem, could be a clinically relevant approach to optimize the efficacy of cochlear implants in restoring ...

LONE TREE, Colo., Oct. 12, 2021 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance ...

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, is proud to highlight the success of Cochlear Link, an innovative customer service offering that makes it easier for ...